Average Co-Inventor Count = 6.52
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Roche Glycart Ag (16 from 68 patents)
2. Hoffmann-la Roche Inc. (10 from 4,942 patents)
3. National Institutes of Health, a Component of the US Dept. of Health & Human Services (1 from 3,435 patents)
4. Roche Glyeart Ag (1 from 3 patents)
5. F. Hoffmann-la Roche Ag (168 patents)
28 patents:
1. 12258371 - Stabilized immunoglobulin domains
2. 12129306 - Antibodies binding to STEAP-1
3. 12049515 - Agonistic CD28 antigen binding molecules targeting Her2
4. 11787873 - Bispecific HER2 antibodies and methods of use
5. 11685790 - Antibodies binding to STEAP-1
6. 11672858 - Bispecific antibody molecules binding to CD3 and TYRP-1
7. 11608376 - Tumor-targeted agonistic CD28 antigen binding molecules
8. 11591397 - Bispecific antibody molecules binding to CD3 and EGFRvIII
9. 11180571 - Antibodies binding to STEAP-1
10. 11130822 - Immunoconjugates
11. 11111312 - Mutant interleukin-2 polypeptides
12. 10975151 - ASPGR antibodies and uses thereof
13. 10781257 - Bispecific T cell activating antigen binding molecules
14. 10781258 - Bispecific T cell activating antigen binding molecules
15. 10584178 - Bispecific HER2 antibodies and methods of use